StockInvest_us Posted - 21 hours ago

Signal alert: $INBX - PivotPoint bottom https://stockinvest.us/l/pv6VpblAOX

Stock_Titan Posted - 1 week ago

$INBX Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off https://www.stocktitan.net/news/INBX/inhibrx-inc-announces-updated-when-issued-trading-date-for-qx75cn38vja9.html

Stock_Titan Posted - 1 week ago

$INBX Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger https://www.stocktitan.net/news/INBX/inhibrx-inc-announces-record-date-and-expected-distribution-time-for-uk8q33xzvl0t.html

DarthGoat Posted - 04/29/24

$INBX IINNN

Elvira007 Posted - 03/27/24

@grod86 a partnership for Alvelestat will move us up $3. Assume $150m upfront and $1b+ in milestones. That should be a minimum. Anything larger upfront or a PIPE at a higher price like $5, and we trade higher in the $5-$7 range. If we get a blockbuster like $INBX , then it likely will be a sale of the entire company. I think $12 would be a minimum bid.

Quantumup Posted - 03/27/24

RBC Capital⬆️PT $KRRO $90 was $70/Outperform~on⬆️conviction for A1AT — thinks KRRO can tackle a broader mkt (liver/lung) w/ preclin data, including non-human primates (NHP) that has shown pot for BiC; sees pot upside into $WVE clin data later this year. rhhby gsk $lly $inbx $sny

Elvira007 Posted - 2 months ago

$MREO next time . Save the expense of taking a trip to come to Miami for a Leerink conference and circle up your Board and potential partners and close a fucking Alvelestat deal. YOUR stock is at $3 and should be over $10 but instead you waste time identifying patients in OI..No need, $RARE already knows these patients and so do all their trial doctors. WE DONT NEED YOU TO BE A COMMERCIAL ORGANIZATION AND DONT WANT YOU TO SELL ANYTHING. LEAVE IT TO THE PROS. THE $INBX deal didn't slow down the process because there is big value there, THE CEO DID DRAGGING HER FEET. DONT GIVE ME ANY BULLSHIT ABIUT WAITING FIR FDA. Doesnt take 18 months..FUCKING AMATEURS

Elvira007 Posted - 2 months ago

$MREO This was actually Mereo's best conference call *fireside chat* CEO has ever had and stock is way down despite she confirmed Alvelestat is worth a lot more now that $INBX sold their program for billions... What idiots had STOP LOSSES of $3.00 LOL

Fullratio Posted - 02/29/24

$INBX debt to equity has soared by 198% from the previous quarter and by 35% YoY: https://fullratio.com/stocks/nasdaq-inbx/inhibrx

Stock_Titan Posted - 02/28/24

$INBX Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results https://www.stocktitan.net/news/INBX/inhibrx-reports-fourth-quarter-and-fiscal-year-2023-financial-1ufq114gz3ay.html

TalkMarkets Posted - 02/28/24

The NVDA Earnings Effect And What It Means For The Current Market Momentum $SPX $CLF $SHAK $INBX https://talkmarkets.com/content/stocks--equities/the-nvda-earnings-effect-and-what-it-means-for-the-current-market-momentum?post=433941&userid=166882

MandoTA Posted - 02/27/24

$INBX 1 hr inverse head and shoulder break

upsidetrader Posted - 02/27/24

$INBX trying to emerge from coil

StockConsultant Posted - 02/27/24

$INBX Inhibrx stock flat top breakout , see https://stockconsultant.com/?INBX

StockConsultant Posted - 02/23/24

$INBX Inhibrx stock flat top breakout watch above 39.42 , see https://stockconsultant.com/?INBX

TroutBearPig Posted - 02/21/24

$INBX Setting up nicely.

upsidetrader Posted - 3 months ago

$INBX Coil much?

fda_tracker Posted - 3 months ago

$INBX Phase 2 trial w/est Feb completion date NCT04950075: https://www.clinicaltrials.gov/study/NCT04950075 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Mergerbrief Posted - 3 months ago

$INBX $SNY - HSR filed By Date mergerbrief.com

Elvira007 Posted - 3 months ago

@Ramach Yes Ramach, if we got a true "rare disease valuation takeout" similar to what $INBX got, the price would be in the $18 range but considering we are at $4.00. Hard to justify as where it trades now .In terms of Rubric, they wanted to sell at $4.00+ and wind down company. Alvlestat value and bone data last year changed all that. $18 does sound nice but the longer this goes without a deal happening, the higher it will continue but this pipeline is prime for a buyout at this level.

JTW014253 Posted - 3 months ago

$PEGY $HOLO $INBX get $PEGY to a dolla on Monday!!!!

Abe21 Posted - 3 months ago

$TOP $INBX Watch out for the next RUNNER $HKD One of the best squeeze in the history happened with $HKD and it can happen again It hit $2400 and $300 and $700 before. We definitely not going to hit theses numbers again but there’s a room to %1000 here DO Not miss out.

StockConsultant Posted - 3 months ago

$INBX Inhibrx stock narrow range breakout watch above 39.42 , see https://stockconsultant.com/?INBX

Elvira007 Posted - 3 months ago

$MREO When they heard $INBX paid$1.7B for a Phase 2 AATD program while Alvelestat is valued at close to nothing...

Elvira007 Posted - 01/31/24

@Jcody1966 Just a guess on my part but with $INBX selling their Phase 2 drug for $1.7B, it makes us looks cheap by 3x. They have been in discussions with partners for their AATD drug for over a year and nothing happened. leads me to believe they are in process of selling . either way, a lot higher

jcooptechit Posted - 01/29/24

$INBX Took 3.30 here. Could not alert sooner as I am driving around today. SERIOUS upside on the chart. Eyeing the gap fill $4.27 - $5.82. Should be home shortly and will provide more updates. $3.56 and $4.09 are key pivots. Another stock coming off of RS & strong $REVB sympathy

Elvira007 Posted - 01/29/24

@douglas98 not happening. This latest move from $2 to $4 is completely different. Reasons being , Undervalued, Pending News, $INBX sale of aatd drug for $1.7B while Alvelestat barely valued above $100m. HC funds will not allow big dips as it has been under heavy accumulation last few weeks... We will break new highs today is my best guess and close near $5 by the weekend

Elvira007 Posted - 01/26/24

$MREO This was Rubric when the heard that $INBX got $1.7B for their AATD drug. "God bless the Queen, we tooooo have one of those bloody AATD drugs called Alvelestat. Charles, Call up Sothebys (ie Centerview Partners)and lets see what we can get.

CEOofstocks Posted - 01/26/24

$MREO So based on what $SNY paid for $INBX AATD candidate (valued at $2.2 billion) , MREO could get $15-$17/ share..... Not to mention ours is a superior delivery method. Crazy potential here.

Elvira007 Posted - 01/25/24

$MREO This recent Sanofi transaction buying $INBX AAATD for $1.7B makes me just think that $AZN is likely gonna have to pay a higher number than they may have originally thought if in fact they are the rumored acquirer for the last year or so.... Assuming we get just $1.0B for our AATD drug (not even going higher). That is about $7.00 per share higher from here..